| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methoxy-UTP |
| 5' Cap | Cap 0 |
| Species | Human |
| RefSeq | NM_001302652.2 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 84334 |
| UniProt ID | Q96IL0 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methoxy-UTP |
| 5' Cap | Cap 0 |
| Species | Human |
| RefSeq | NM_001302652.2 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 84334 |
| UniProt ID | Q96IL0 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human APOPT1, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) (GTTS-WK22240MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK13075MR | IVTScrip™ mRNA-Human ACTRT3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) | mRNA | ACTRT3 |
| GTTS-WK28035MR | IVTScrip™ mRNA-Human ARL14, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) | mRNA | ARL14 |
| GTTS-WK23033MR | IVTScrip™ mRNA-Human ASXL3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) | mRNA | ASXL3 |
| GTTS-WK19036MR | IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) | mRNA | alpha-Sarcoglycan |
| GTTS-WK21708MR | IVTScrip™ mRNA-Human ARHGEF11, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) | mRNA | ARHGEF11 |
| GTTS-WK23804MR | IVTScrip™ mRNA-Human ARHGDIA, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) | mRNA | ARHGDIA |
| GTTS-WK23501MR | IVTScrip™ mRNA-Human ARHGAP5, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) | mRNA | ARHGAP5 |
| GTTS-WK14917MR | IVTScrip™ mRNA-Human ANKRD31, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | ANKRD31 |